These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
48 related items for PubMed ID: 17632076
1. SIRPalpha1 and SIRPalpha2: their role as tumor suppressors in breast carcinoma cells. Yamasaki Y, Ito S, Tsunoda N, Kokuryo T, Hara K, Senga T, Kannagi R, Yamamoto T, Oda K, Nagino M, Nimura Y, Hamaguchi M. Biochem Biophys Res Commun; 2007 Sep 14; 361(1):7-13. PubMed ID: 17632076 [Abstract] [Full Text] [Related]
2. Recovery of anoikis in Src-transformed cells and human breast carcinoma cells by restoration of the SIRP α1/SHP-2 signaling system. Hara K, Senga T, Biswas MH, Hasegawa H, Ito S, Hyodo T, Hirooka Y, Niwa Y, Goto H, Hamaguchi M. Cancer Res; 2011 Feb 15; 71(4):1229-34. PubMed ID: 21169408 [Abstract] [Full Text] [Related]
3. Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1. Yan HX, Wang HY, Zhang R, Chen L, Li BA, Liu SQ, Cao HF, Qiu XH, Shan YF, Yan ZH, Wu HP, Tan YX, Wu MC. Hepatology; 2004 Sep 15; 40(3):618-28. PubMed ID: 15349900 [Abstract] [Full Text] [Related]
4. SHPS-1: a budding molecule against cancer dissemination. Oshima K, Machida K, Ichigotani Y, Nimura Y, Shirafuji N, Hamaguchi M, Matsuda S. Cancer Res; 2002 Jul 15; 62(14):3929-33. PubMed ID: 12124321 [Abstract] [Full Text] [Related]
5. Effect of Sirpalpha1 on the expression of nuclear factor-kappa B in hepatocellular carcinoma. Qin JM, Wan XW, Zeng JZ, Wu MC. Hepatobiliary Pancreat Dis Int; 2007 Jun 15; 6(3):276-83. PubMed ID: 17548251 [Abstract] [Full Text] [Related]
6. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ. Breast Cancer Res Treat; 2009 Feb 15; 113(3):443-56. PubMed ID: 18327707 [Abstract] [Full Text] [Related]
7. Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines. Stoeger SM, Cowan KH. Cancer Chemother Pharmacol; 2009 Apr 15; 63(5):807-18. PubMed ID: 18661133 [Abstract] [Full Text] [Related]
8. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells. Moh MC, Zhang T, Lee LH, Shen S. Carcinogenesis; 2008 Dec 15; 29(12):2298-305. PubMed ID: 18845560 [Abstract] [Full Text] [Related]
9. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Li HZ, Wang Y, Gao Y, Shao J, Zhao XL, Deng WM, Liu YX, Yang J, Yao Z. Mol Cancer Res; 2008 Jun 15; 6(6):917-28. PubMed ID: 18567796 [Abstract] [Full Text] [Related]
10. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. Chiu ST, Chang KJ, Ting CH, Shen HC, Li H, Hsieh FJ. Carcinogenesis; 2009 Sep 15; 30(9):1475-86. PubMed ID: 19483190 [Abstract] [Full Text] [Related]
11. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Tsang WP, Kwok TT. Carcinogenesis; 2009 Jun 15; 30(6):953-9. PubMed ID: 19372139 [Abstract] [Full Text] [Related]
12. The geodiamolide H, derived from Brazilian sponge Geodia corticostylifera, regulates actin cytoskeleton, migration and invasion of breast cancer cells cultured in three-dimensional environment. Freitas VM, Rangel M, Bisson LF, Jaeger RG, Machado-Santelli GM. J Cell Physiol; 2008 Sep 15; 216(3):583-94. PubMed ID: 18330887 [Abstract] [Full Text] [Related]
13. SIRPalpha1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration. Kapoor GS, O'Rourke DM. Oncogene; 2010 Jul 22; 29(29):4130-44. PubMed ID: 20473329 [Abstract] [Full Text] [Related]
14. Identification and characterization of human ARIP2 and its relation to breast cancer. Li ZD, Wu Y, Bao YL, Yu CL, Guan LL, Wang YZ, Meng XY, Li YX. Cytokine; 2009 May 22; 46(2):251-9. PubMed ID: 19349195 [Abstract] [Full Text] [Related]
15. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Kim A, Kim MJ, Yang Y, Kim JW, Yeom YI, Lim JS. Carcinogenesis; 2009 Jun 22; 30(6):927-36. PubMed ID: 19336468 [Abstract] [Full Text] [Related]
16. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model. Yanagie H, Tanabe T, Sumimoto H, Sugiyama H, Matsuda S, Nonaka Y, Ogiwara N, Sasaki K, Tani K, Takamoto S, Takahashi H, Eriguchi M. Biomed Pharmacother; 2009 May 22; 63(4):275-86. PubMed ID: 18657378 [Abstract] [Full Text] [Related]
17. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM. J Pharmacol Exp Ther; 2009 Jun 22; 329(3):1063-70. PubMed ID: 19258520 [Abstract] [Full Text] [Related]
18. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells. Hui AY, Meens JA, Schick C, Organ SL, Qiao H, Tremblay EA, Schaeffer E, Uniyal S, Chan BM, Elliott BE. J Cell Biochem; 2009 Aug 15; 107(6):1168-81. PubMed ID: 19533669 [Abstract] [Full Text] [Related]
19. RASSF1A expression inhibits cell growth and enhances cell chemosensitivity to mitomycin in BEL-7402 hepatocellular carcinoma cells. Guan HG, Xue WJ, Qian HX, Zhou XJ, Qin L, Lan J. Chin Med J (Engl); 2009 Jun 05; 122(11):1328-32. PubMed ID: 19567146 [Abstract] [Full Text] [Related]
20. A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9. Ruhul Amin AR, Uddin Biswas MH, Senga T, Feng GS, Kannagi R, Agarwal ML, Hamaguchi M. Genes Cells; 2007 Sep 05; 12(9):1023-33. PubMed ID: 17825046 [Abstract] [Full Text] [Related] Page: [Next] [New Search]